Investors Buy up Stocks in Biggest Follow-on Offering Day in Biotech History
December 11, 2025
Endpoints News is calling December 10 the busiest day ever in biotech, with the most follow-on proceeds in a single day. A record-setting $3.2B in biotech follow-on stock offerings were sold, indicating public investors’ appetite for biotech investment. From late Tuesday evening into Wednesday morning, eight biotechs priced sales of new stocks, and seven of those companies increased their offering sizes to meet demand.
Utah’s own Denali Therapeutics was among the biotechs raising funds.
Recent News
- Nucleus Institute Convergence Point Groundbreaking
- EDWARDS LIFESCIENCES RECEIVES FDA APPROVAL FOR AUTUS VALVE
- Route 92 Medical Announces U.S. FDA Clearance for the FreeClimb® 46 Catheter with Tenzing® 4
- Owlet Announces Creation of Baby Safety Task Force to Educate, Innovate, and Advocate for Better Baby Safety Standards
- BD Celebrates 70 Years of Manufacturing, Innovation and Community Partnership in Sandy
- Freyya Closes Oversubscribed Pre-Seed Financing to Advance FDA Regulatory Milestones, Commercialization
